Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas? usponline COVID19 SARSCoV2 MycosisFungoides TCellLymphoma

By Dr. Chinta SidharthanOct 17 2022Reviewed by Aimee Molineux In a recent clinical letter published by the Brazilian Society of Dermatology, researchers highlight the potential role of severe acute respiratory syndrome coronavirus 2 infections in triggering the relapse of mycosis fungoides, a type of cutaneous T-cell lymphoma.

Two weeks later, pruritis was observed in the areas with erythema, and the papules got desquamated and flattened. After two months, the papules on the limbs, abdomen, and trunk of the patient changed into parchment-like plaques. Findings The authors discussed the immunological dysregulation associated with SARS-CoV-2 infections that could potentially increase the risk of IB cutaneous T-cell lymphomas such as Sézary syndrome and mycosis fungoides.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Reduced initiation and duration of breastfeeding in SARS-CoV-2-positive mothersA recent study published in the journal Academic Pediatrics evaluated the associations between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and early breastfeeding.
Read more »

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2 Coronavirus Disease COVID Metabolites SARSCoV2 StructuralChemistry SpringerNature
Read more »

Inhalation therapeutics against COVID-19A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).
Read more »

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illnessTwo cases of acute abdominal pain in patients with COVID-19 in their second week of illness JaypeeJournals pain coronavirus covid COVID19 illness
Read more »